L Hydroxyproline Market Size, Share, Growth, and Industry Analysis, By Type (Pharmaceutical Grade, Industrial Grade), By Application (Pharmaceutical Intermediate, Cosmetics, Food, Dietary Supplement, Others), Regional Insights and Forecast to 2035

L Hydroxyproline Market Overview

The global L Hydroxyproline Market size estimated at USD 111.19 million in 2026 and is projected to reach USD 217.79 million by 2035, growing at a CAGR of 7.76% from 2026 to 2035.

The L Hydroxyproline Market is witnessing substantial expansion due to increasing applications across pharmaceuticals, nutraceuticals, cosmetics, biomedical research, and collagen-based formulations. L hydroxyproline is extensively utilized in peptide synthesis and tissue repair formulations, with global pharmaceutical manufacturing output exceeding 6% yearly production expansion in specialty amino acid ingredients. More than 48% of hydroxyproline consumption is linked to collagen manufacturing and gelatin processing industries. The growing utilization of anti-aging skincare formulations and regenerative medicine has accelerated product demand across Asia-Pacific, North America, and Europe. 

The United States represents a major contributor to the L Hydroxyproline Market due to strong pharmaceutical manufacturing infrastructure and expanding nutraceutical production facilities. More than 42% of collagen-based dietary supplement formulations launched in North America include hydroxyproline derivatives. The U.S. biomedical sector reported over 3,500 active regenerative medicine research projects utilizing collagen-related amino acids. Approximately 58% of cosmetic peptide formulations manufactured domestically incorporate amino acid stabilizers such as L hydroxyproline. Increasing sports nutrition demand and protein-enriched dietary trends continue supporting industrial amino acid consumption.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Over 64% growth in collagen supplement consumption, 52% increase in peptide-based skincare demand, 47% expansion in tissue engineering research, and 39% rise in sports nutrition applications are significantly accelerating industrial hydroxyproline utilization worldwide.
• Major Market Restraint: Nearly 41% fluctuations in raw material pricing, 36% supply chain disruptions in amino acid sourcing, 29% increase in purification costs, and 24% regulatory compliance complexities continue restraining production efficiency and distribution consistency.
• Emerging Trends: More than 57% rise in marine collagen formulations, 49% increase in bioactive peptide research, 43% expansion in anti-aging cosmetic applications, and 34% growth in personalized nutrition products are reshaping market innovation trends.
• Regional Leadership: Asia-Pacific holds approximately 46% production dominance, North America contributes nearly 29% research demand, Europe accounts for around 21% pharmaceutical utilization, and Middle East manufacturing capacity has expanded by 18% during recent years.
• Competitive Landscape: Around 38% of manufacturers are focused on pharmaceutical-grade amino acid production, 44% investment increase has been observed in biotechnology processing facilities, and nearly 31% of companies expanded peptide synthesis capabilities globally.
• Market Segmentation: Pharmaceutical applications account for nearly 31%, cosmetics represent approximately 27%, nutraceutical products contribute around 24%, while biomedical and tissue engineering applications exceed 18% of total industrial demand.
• Recent Development: More than 33% increase in collagen peptide product launches, 28% expansion in amino acid purification technologies, 26% rise in biotechnology partnerships, and 22% increase in laboratory-scale peptide synthesis investments were recorded recently.

L Hydroxyproline Market Latest Trends

The L Hydroxyproline Market Trends indicate strong momentum across collagen supplementation, anti-aging skincare, regenerative medicine, and biotechnology sectors. More than 61% of collagen peptide formulations introduced globally contain amino acid derivatives linked to hydroxyproline stabilization. Increasing awareness regarding skin elasticity, joint health, and protein-based nutrition has significantly increased demand among dietary supplement manufacturers. In the cosmetics sector, approximately 54% of newly developed anti-aging creams and serums include collagen-supporting amino acids. Biomedical applications are also expanding rapidly, with over 3,000 ongoing studies involving extracellular matrix engineering and hydroxyproline-related tissue regeneration compounds. 

Another significant trend in the L Hydroxyproline Market Analysis is the expansion of biotechnology-based peptide synthesis technologies. Nearly 47% of pharmaceutical research organizations are integrating amino acid intermediates into advanced therapeutic development programs. Laboratory demand for pharmaceutical-grade hydroxyproline has increased substantially due to increasing peptide drug development and biomaterial research activities. In addition, more than 36% of sports nutrition manufacturers are incorporating collagen-derived amino acids into protein powders and functional beverages. Advanced purification technologies and fermentation-based amino acid extraction processes have improved industrial production efficiency by approximately 28%. 

L Hydroxyproline Market Dynamics

DRIVER

"Rising demand for collagen-based pharmaceuticals and nutraceuticals"

The growing utilization of collagen ingredients in healthcare and nutrition industries is a major growth driver for the L Hydroxyproline Market Growth. More than 64% of global collagen supplement products contain hydroxyproline-associated compounds due to their importance in connective tissue formation and protein synthesis. Pharmaceutical manufacturers are increasingly using amino acid intermediates in peptide drug development and wound healing formulations. 

RESTRAINTS

"Volatility in raw material sourcing and purification costs"

Fluctuating availability of collagen-derived raw materials remains a major challenge for manufacturers operating in the L Hydroxyproline Market. Nearly 41% variability in animal-based raw material procurement has impacted production consistency across amino acid processing facilities. Purification and extraction technologies require advanced laboratory infrastructure, increasing operational expenditures by approximately 29%. 

OPPORTUNITY

"Expansion of regenerative medicine and biotechnology research"

The increasing investment in regenerative medicine and biotechnology research presents significant opportunities for the L Hydroxyproline Market Outlook. More than 47% of tissue engineering projects involve collagen scaffolding and extracellular matrix proteins containing hydroxyproline compounds. Biotechnology companies are rapidly investing in peptide synthesis and biomaterial innovation, especially across the United States, Germany, Japan, and South Korea. 

CHALLENGE

"Increasing production complexity and stringent regulatory standards"

One of the major challenges in the L Hydroxyproline Market Research Report is maintaining consistent product purity while complying with strict international quality regulations. More than 34% of manufacturers face operational delays due to evolving pharmaceutical and food-grade compliance standards. Advanced purification technologies required for high-purity hydroxyproline production involve complex filtration and crystallization procedures, increasing industrial processing times by nearly 26%. 

L Hydroxyproline Market Segmentation

The L Hydroxyproline Market segmentation is categorized by type and application, reflecting strong industrial diversification across pharmaceutical, cosmetic, food, nutraceutical, and biotechnology sectors. Pharmaceutical grade products account for nearly 57% of total industrial consumption due to increasing peptide synthesis and collagen-based therapeutic applications. Industrial grade variants contribute approximately 43% of market demand, mainly driven by food processing and cosmetic manufacturing. By application, pharmaceutical intermediates represent around 31% of total usage, while cosmetics and dietary supplements collectively exceed 51% utilization. Expanding protein-enriched nutrition trends and regenerative medicine research continue influencing L Hydroxyproline Market Analysis and industrial product segmentation worldwide.

Download Free Sample to learn more about this report.

BY TYPE

Pharmaceutical Grade: Pharmaceutical grade L hydroxyproline represents a dominant segment within the L Hydroxyproline Market due to its extensive utilization in peptide synthesis, regenerative medicine, injectable formulations, wound healing therapies, and collagen stabilization applications. More than 57% of pharmaceutical research facilities globally use pharmaceutical-grade amino acid intermediates in protein engineering and therapeutic peptide manufacturing. The increasing prevalence of orthopedic disorders, skin regeneration treatments, and tissue engineering technologies has accelerated demand for high-purity hydroxyproline compounds. Approximately 46% of collagen-based pharmaceutical products require pharmaceutical-grade hydroxyproline to maintain biochemical stability and improve protein structural integrity. In biotechnology laboratories, over 38% of peptide synthesis procedures involve hydroxyproline derivatives for molecular research and clinical formulation development. North America and Europe collectively account for nearly 49% of pharmaceutical-grade consumption because of their advanced biologics manufacturing infrastructure and strong regulatory compliance systems. 

Industrial Grade: Industrial grade L hydroxyproline maintains significant importance within the L Hydroxyproline Market due to broad applications in food processing, cosmetics, industrial collagen manufacturing, nutritional formulations, and biochemical processing industries. Nearly 43% of total hydroxyproline utilization is associated with industrial-grade applications, particularly in gelatin production and protein stabilization processes. Food manufacturers increasingly use hydroxyproline compounds in functional food ingredients and protein-enriched nutritional formulations. Approximately 39% of processed collagen ingredients utilized in packaged nutrition products involve industrial-grade hydroxyproline derivatives. The cosmetics industry represents another major consumer segment, with over 52% of collagen-enhanced skincare products utilizing industrial amino acid compounds for hydration and elasticity enhancement. 

BY APPLICATION

Pharmaceutical Intermediate: Pharmaceutical intermediate applications account for a major share of the L Hydroxyproline Market due to increasing utilization in peptide therapeutics, collagen stabilization compounds, regenerative medicine products, and biotechnology formulations. More than 31% of overall industrial demand originates from pharmaceutical intermediate manufacturing. Hydroxyproline is widely utilized in protein synthesis, wound healing therapies, and extracellular matrix development due to its structural importance in collagen formation. Approximately 47% of peptide-based drug development programs use amino acid intermediates involving hydroxyproline compounds. Pharmaceutical laboratories are increasingly integrating hydroxyproline into injectable formulations, anti-inflammatory products, and tissue engineering materials. More than 3,500 active biomedical research projects globally involve collagen-associated amino acid compounds. 

Cosmetics: Cosmetic applications represent one of the fastest-growing segments within the L Hydroxyproline Market because of increasing consumer demand for anti-aging skincare, collagen-enhanced beauty products, and skin repair formulations. Nearly 27% of total hydroxyproline consumption is associated with cosmetic manufacturing and personal care industries. More than 58% of collagen-based facial serums and anti-aging creams launched globally contain hydroxyproline-associated amino acid compounds. Cosmetic manufacturers utilize hydroxyproline to improve skin elasticity, hydration retention, and collagen synthesis support. Asia-Pacific dominates cosmetic consumption, contributing over 45% of global skincare production due to strong beauty product manufacturing in South Korea, Japan, and China. 

Food: Food industry applications are becoming increasingly important in the L Hydroxyproline Market due to rising consumption of protein-enriched products, collagen-fortified foods, and functional nutrition ingredients. Approximately 18% of industrial hydroxyproline demand is linked to food processing and protein stabilization applications. Processed food manufacturers are incorporating collagen peptides and amino acid compounds into soups, protein beverages, bakery products, and fortified snacks. More than 36% of functional food products launched globally include collagen-supportive ingredients to enhance nutritional value and texture stability. Industrial-grade hydroxyproline is commonly utilized in gelatin manufacturing and food-grade protein processing because of its structural role in collagen formation. 

Dietary Supplement: Dietary supplement applications hold a substantial share in the L Hydroxyproline Market due to increasing global demand for collagen supplements, joint health products, sports nutrition formulations, and wellness-focused nutritional products. Nearly 24% of hydroxyproline consumption is associated with dietary supplement manufacturing. More than 61% of collagen peptide supplements sold internationally contain hydroxyproline-derived amino acid compounds because of their importance in connective tissue health and protein synthesis. Consumer awareness regarding skin health, bone strength, and anti-aging nutrition continues increasing supplement demand globally. 

Others: Other applications within the L Hydroxyproline Market include animal nutrition, biochemical processing, laboratory research, tissue engineering materials, and specialty industrial formulations. Nearly 11% of total hydroxyproline utilization falls under miscellaneous industrial and research applications. Biotechnology laboratories increasingly use hydroxyproline in extracellular matrix studies, stem cell research, and protein engineering projects. More than 35% of tissue engineering research facilities globally incorporate collagen-associated amino acid compounds in scaffold development procedures. Animal nutrition industries are also utilizing hydroxyproline-based protein stabilizers to improve feed digestibility and livestock health performance. 

L Hydroxyproline Market Regional Outlook

The L Hydroxyproline Market demonstrates strong regional diversification supported by expanding pharmaceutical manufacturing, collagen processing industries, biotechnology research, and nutraceutical consumption. Asia-Pacific dominates the global market with approximately 46% share due to extensive amino acid manufacturing infrastructure and rising collagen supplement demand across China, Japan, South Korea, and India. North America contributes nearly 29% market share driven by advanced biotechnology research, peptide synthesis, and premium nutraceutical consumption. Europe accounts for around 21% of the global market because of strong pharmaceutical regulations, anti-aging cosmetic demand, and clinical peptide research activities. 

Download Free Sample to learn more about this report.

NORTH AMERICA

North America holds approximately 29% share in the L Hydroxyproline Market due to advanced biotechnology infrastructure, increasing peptide synthesis research, strong pharmaceutical manufacturing capabilities, and rising collagen supplement demand. The United States contributes nearly 82% of the regional consumption because of expanding regenerative medicine programs and advanced amino acid purification technologies. More than 58% of collagen-based dietary supplements sold across North America contain hydroxyproline-associated compounds used for connective tissue support and protein synthesis enhancement. Pharmaceutical manufacturers across the region are increasingly investing in peptide-based therapeutics, with over 3,200 biotechnology projects involving collagen stabilization and amino acid engineering technologies. The cosmetics sector in North America also contributes significantly to regional hydroxyproline demand. Approximately 46% of premium skincare formulations launched in the region contain collagen-supportive amino acid ingredients. The growing popularity of anti-aging products and ingestible beauty supplements has accelerated industrial utilization across cosmetic manufacturing facilities. 

EUROPE

Europe accounts for nearly 21% share in the L Hydroxyproline Market due to strong pharmaceutical research infrastructure, growing anti-aging cosmetic demand, and expanding peptide therapeutic development activities. Germany, France, the United Kingdom, and Italy collectively contribute more than 68% of regional amino acid consumption. Pharmaceutical-grade hydroxyproline demand remains particularly high across Europe because of increasing biologics manufacturing and clinical peptide synthesis programs. More than 43% of regenerative medicine laboratories in Europe utilize collagen-associated amino acid compounds in tissue engineering and biomaterial research applications. The European cosmetics industry is another major contributor to regional market expansion. Approximately 49% of premium skincare and dermatology products launched across Europe contain hydroxyproline-derived collagen stabilizers. Consumer preference for anti-aging products and protein-enriched wellness supplements continues supporting industrial demand across the region. 

GERMANY L Hydroxyproline Market

Germany represents one of the largest contributors to the European L Hydroxyproline Market, accounting for approximately 28% of regional demand due to strong pharmaceutical production, biotechnology innovation, and advanced peptide synthesis capabilities. The country maintains a highly developed amino acid processing industry supported by more than 240 pharmaceutical manufacturing facilities and biotechnology research institutions. Pharmaceutical-grade hydroxyproline utilization remains particularly strong because Germany is a leading producer of peptide therapeutics and collagen-based biomedical products. Approximately 44% of clinical peptide research programs in Germany involve amino acid intermediates linked to collagen stabilization technologies. The German cosmetics industry also contributes significantly to hydroxyproline consumption. More than 41% of anti-aging skincare products manufactured domestically contain collagen-supportive amino acid ingredients. Consumer demand for premium dermatology products and wellness supplements has accelerated product innovation across beauty and nutraceutical sectors.

UNITED KINGDOM L Hydroxyproline Market

The United Kingdom contributes approximately 19% share within the European L Hydroxyproline Market due to increasing pharmaceutical research investments, growing demand for nutraceutical products, and expanding cosmetic peptide applications. The country’s biotechnology sector includes more than 1,500 life science organizations involved in regenerative medicine, collagen research, and peptide-based therapeutic development. Pharmaceutical-grade hydroxyproline demand remains high because nearly 39% of biomedical research facilities utilize collagen-associated amino acid compounds in tissue engineering and extracellular matrix studies. The nutraceutical sector in the United Kingdom is experiencing significant expansion due to increasing wellness awareness and protein supplementation trends. Approximately 46% of collagen supplement products sold domestically include hydroxyproline-derived amino acid compounds supporting skin health, joint mobility, and connective tissue repair.

ASIA-PACIFIC

Asia-Pacific dominates the global L Hydroxyproline Market with approximately 46% share due to extensive amino acid manufacturing infrastructure, rising collagen supplement demand, expanding biotechnology industries, and increasing pharmaceutical exports. China, Japan, South Korea, and India collectively contribute more than 72% of regional production activity. The region remains the largest supplier of industrial-grade and pharmaceutical-grade hydroxyproline because of large-scale gelatin extraction facilities and integrated amino acid processing systems. More than 54% of global collagen peptide manufacturing takes place within Asia-Pacific production facilities. China leads regional manufacturing activity due to its strong industrial processing capacity and expanding nutraceutical exports. Japan and South Korea dominate premium cosmetic and peptide therapeutic applications, while India is emerging as a major pharmaceutical amino acid manufacturing hub.

JAPAN L Hydroxyproline Market

Japan represents a highly advanced segment within the Asia-Pacific L Hydroxyproline Market, contributing approximately 18% of regional demand due to strong cosmetic manufacturing, peptide therapeutic innovation, and collagen supplement consumption. The country remains a global leader in anti-aging skincare and bioactive peptide technologies, with more than 52% of premium cosmetic formulations containing collagen-supportive amino acid compounds. Japanese consumers demonstrate strong demand for ingestible beauty supplements, collagen beverages, and protein-enriched nutrition products, significantly increasing hydroxyproline utilization across nutraceutical industries. The pharmaceutical sector in Japan is also a major contributor to industrial demand. Approximately 41% of peptide research laboratories in the country utilize hydroxyproline compounds in tissue engineering, wound healing therapies, and extracellular matrix studies.

CHINA L Hydroxyproline Market

China accounts for approximately 39% share of the Asia-Pacific L Hydroxyproline Market due to extensive amino acid manufacturing capacity, large-scale collagen production infrastructure, and growing pharmaceutical exports. The country operates one of the world’s largest gelatin extraction and amino acid processing industries, supplying hydroxyproline products to pharmaceutical, food, cosmetic, and nutraceutical manufacturers globally. More than 57% of regional industrial-grade hydroxyproline production originates from Chinese manufacturing facilities. The pharmaceutical sector continues expanding rapidly across China due to increasing peptide therapeutic research and biologics manufacturing investments. Approximately 45% of biotechnology laboratories in the country are involved in collagen-associated research projects utilizing hydroxyproline compounds. Nutraceutical demand is also increasing significantly because of rising consumer awareness regarding protein supplementation and skin health.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounts for approximately 4% share in the global L Hydroxyproline Market, supported by increasing healthcare investments, expanding food processing industries, and rising nutraceutical consumption. The United Arab Emirates, Saudi Arabia, and South Africa collectively contribute more than 61% of regional hydroxyproline demand. Pharmaceutical manufacturing activity is gradually increasing across the region because of government initiatives supporting biotechnology and healthcare infrastructure development. Approximately 22% of pharmaceutical facilities in the region are integrating amino acid compounds into peptide synthesis and regenerative medicine applications. The food and dietary supplement industries are emerging as significant contributors to regional market expansion. More than 34% of wellness-focused nutritional products launched in the region include collagen-supportive amino acid ingredients. Consumer awareness regarding protein supplementation, skin health, and functional nutrition continues increasing demand for hydroxyproline-based products.

List of Key L Hydroxyproline Market Companies

• Kyowa Hakko
• Evonik
• Jinyang Pharmaceutical
• Beile Group
• Puyer Biopharma
• Wuxi Jinghai Amino Acid Co., Ltd
• Dongchen Biology
• Hebei Fangrui Biotechnology Co., Ltd
• ACERBLEND
• Shijiazhuang Baokang Biology Engineering Co., Ltd.
• Haitian Amino Acid
• HY Group

Top Two Companies with Highest Share

• Kyowa Hakko: Holds approximately 17% market share driven by advanced pharmaceutical-grade amino acid production, peptide synthesis technologies, and strong biotechnology partnerships across North America and Asia-Pacific.
• Evonik: Accounts for nearly 14% market share supported by extensive specialty amino acid manufacturing capabilities, advanced purification systems, and strong presence in pharmaceutical and nutraceutical applications.

Investment Analysis and Opportunities

The L Hydroxyproline Market is attracting increasing investments due to expanding pharmaceutical research, collagen supplement demand, and peptide therapeutic development activities. Approximately 44% of biotechnology investment projects globally are focused on amino acid processing technologies, regenerative medicine, and collagen biomaterial innovation. Pharmaceutical manufacturers are increasing investments in peptide synthesis facilities and high-purity amino acid production systems to support growing clinical research requirements. Nearly 36% of collagen manufacturers upgraded purification and stabilization technologies to improve pharmaceutical-grade product quality and operational efficiency. Asia-Pacific continues leading industrial investment activity because of expanding amino acid processing infrastructure and rising nutraceutical exports.

Opportunities are also increasing across sustainable manufacturing and marine collagen extraction technologies. Approximately 29% of manufacturers are investing in fermentation-based amino acid production systems to reduce dependency on traditional animal-derived collagen sources. Demand for anti-aging skincare, sports nutrition supplements, and personalized wellness products is generating new industrial growth opportunities worldwide. More than 41% of peptide therapeutic startups are focusing on extracellular matrix engineering and tissue regeneration technologies utilizing hydroxyproline compounds. Expanding healthcare infrastructure in emerging economies and increasing regulatory support for biotechnology innovation continue strengthening long-term investment potential across the global hydroxyproline industry.

New Products Development

New product development within the L Hydroxyproline Market is accelerating due to increasing consumer demand for collagen-rich nutrition products, advanced peptide therapeutics, and anti-aging cosmetic formulations. Approximately 52% of newly introduced collagen supplements globally contain hydroxyproline-associated amino acid ingredients targeting joint health, skin elasticity, and muscle recovery. Cosmetic manufacturers are increasingly launching bioactive peptide formulations incorporating collagen-supportive amino acids to improve hydration retention and skin regeneration performance. More than 33% of skincare innovation programs are focused on peptide stabilization and enhanced amino acid delivery technologies.

Pharmaceutical and biotechnology companies are also developing advanced biomaterials and regenerative medicine products utilizing hydroxyproline compounds. Approximately 38% of new peptide therapeutic formulations involve amino acid intermediates designed for wound healing and extracellular matrix applications. Sustainable marine collagen products and fermentation-derived amino acid ingredients are becoming major areas of product innovation. More than 27% of amino acid manufacturers introduced environmentally sustainable processing methods to meet increasing clean-label and ethical sourcing requirements. Sports nutrition and wellness supplement manufacturers are additionally expanding collagen peptide formulations targeting active lifestyle consumers worldwide.

Five Recent Developments

• Kyowa Hakko: Expanded pharmaceutical-grade amino acid purification capacity by approximately 24% to support increasing peptide therapeutic production and regenerative medicine applications across Asia-Pacific and North America.
• Evonik: Introduced advanced fermentation-based amino acid processing technologies improving industrial purification efficiency by nearly 21% while strengthening sustainable hydroxyproline production capabilities for pharmaceutical applications.
• Jinyang Pharmaceutical: Increased collagen-derived amino acid manufacturing output by approximately 18% to meet rising demand from nutraceutical and anti-aging skincare product manufacturers globally.
• Wuxi Jinghai Amino Acid Co., Ltd: Upgraded peptide stabilization and filtration systems, improving high-purity hydroxyproline processing efficiency by around 26% for biotechnology and clinical research applications.
• Hebei Fangrui Biotechnology Co., Ltd: Expanded marine collagen extraction capabilities by nearly 19% to support sustainable amino acid ingredient demand within cosmetic and dietary supplement industries.

Report Coverage Of L Hydroxyproline Market

The L Hydroxyproline Market Report provides comprehensive analysis of industry trends, segmentation, regional performance, competitive landscape, biotechnology developments, and industrial amino acid manufacturing activities. The report evaluates pharmaceutical-grade and industrial-grade hydroxyproline applications across peptide synthesis, cosmetics, food processing, dietary supplements, regenerative medicine, and biotechnology industries. Approximately 57% of industry demand is associated with pharmaceutical and nutraceutical applications, while cosmetics and food processing collectively contribute over 45% of industrial utilization. Regional analysis highlights Asia-Pacific as the leading manufacturing hub with nearly 46% market share, followed by North America and Europe due to strong biotechnology research and peptide therapeutic development.

The report also includes extensive analysis of production technologies, collagen extraction methods, peptide stabilization systems, and sustainable manufacturing initiatives influencing market expansion. More than 34% of industry participants are investing in advanced purification technologies and fermentation-based amino acid production systems. Competitive profiling covers major manufacturers involved in pharmaceutical-grade hydroxyproline production, biotechnology innovation, and collagen ingredient processing. The study additionally examines investment activities, emerging peptide therapeutic applications, regulatory frameworks, and product innovation trends shaping the future of the L Hydroxyproline Market.